Picco V - Search Results

1

Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.

Benhamou Y, Picco V, Raybaud H, Sudaka A, Chamorey E, Brolih S, Monteverde M, Merlano M, Lo Nigro C, Ambrosetti D, Pagès G. Benhamou Y, et al. Among authors: picco v. Oncotarget. 2016 Jul 12;7(28):44236-44251. doi: 10.18632/oncotarget.10005. Oncotarget. 2016. PMID: 27329590 Free PMC article.

2

Linking JNK Activity to the DNA Damage Response.

Picco V, Pagès G. Picco V, et al. Genes Cancer. 2013 Sep;4(9-10):360-8. doi: 10.1177/1947601913486347. Genes Cancer. 2013. PMID: 24349633 Free PMC article. Review.

3

The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma.

Benhamou Y, Picco V, Pagès G. Benhamou Y, et al. Among authors: picco v. Oral Oncol. 2016 Jun;57:46-53. doi: 10.1016/j.oraloncology.2016.04.006. Epub 2016 Apr 28. Oral Oncol. 2016. PMID: 27208844 Review.

4

ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2.

Picco V, Coste I, Giraud-Panis MJ, Renno T, Gilson E, Pagès G. Picco V, et al. Oncotarget. 2016 Jul 19;7(29):46615-46627. doi: 10.18632/oncotarget.10316. Oncotarget. 2016. PMID: 27366950 Free PMC article.

5

The c-Jun N-terminal kinase prevents oxidative stress induced by UV and thermal stresses in corals and human cells.

Courtial L, Picco V, Grover R, Cormerais Y, Rottier C, Labbe A, Pagès G, Ferrier-Pagès C. Courtial L, et al. Among authors: picco v. Sci Rep. 2017 Apr 4;7:45713. doi: 10.1038/srep45713. Sci Rep. 2017. PMID: 28374828 Free PMC article.

6

Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata.

Courtial L, Picco V, Pagès G, Ferrier-Pagès C. Courtial L, et al. Among authors: picco v. F1000Res. 2017 Apr 26;6:577. doi: 10.12688/f1000research.11365.2. eCollection 2017. F1000Res. 2017. PMID: 28690832 Free PMC article.

7

AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.

Brolih S, Parks SK, Vial V, Durivault J, Mostosi L, Pouysségur J, Pagès G, Picco V. Brolih S, et al. Among authors: picco v. BMC Cancer. 2018 Mar 5;18(1):249. doi: 10.1186/s12885-018-4169-0. BMC Cancer. 2018. PMID: 29506489 Free PMC article.

8

Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.

Cormerais Y, Pagnuzzi-Boncompagni M, Schrötter S, Giuliano S, Tambutté E, Endou H, Wempe MF, Pagès G, Pouysségur J, Picco V. Cormerais Y, et al. Among authors: picco v. J Cell Mol Med. 2019 Apr;23(4):2711-2718. doi: 10.1111/jcmm.14176. Epub 2019 Feb 19. J Cell Mol Med. 2019. PMID: 30784173 Free PMC article.

9

VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.

Penco-Campillo M, Comoglio Y, Feliz Morel ÁJ, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford SC, Claren A, Doyen J, Picco V, Martial S, Pagès G. Penco-Campillo M, et al. Among authors: picco v. Commun Biol. 2020 Oct 16;3(1):579. doi: 10.1038/s42003-020-01306-4. Commun Biol. 2020. PMID: 33067561 Free PMC article.

10

Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.

Penco-Campillo M, Comoglio Y, Feliz Morel ÁJ, Hanna R, Durivault J, Leloire M, Mejias B, Pagnuzzi M, Morot A, Burel-Vandenbos F, Selby M, Williamson D, Clifford SC, Claren A, Doyen J, Picco V, Martial S, Pagès G. Penco-Campillo M, et al. Among authors: picco v. Commun Biol. 2020 Dec 7;3(1):758. doi: 10.1038/s42003-020-01502-2. Commun Biol. 2020. PMID: 33288846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters